[EFFECT] GeoVax Labs, Inc. Warrants SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

EFFECT

07/01/2025 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 30, 2025 5:00 P.M.

Form:

S-1

CIK:	0000832489
Company Name:	GeoVax Labs, Inc.
File Number:	333-288085

Source: View Original Filing on SEC EDGAR

Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

GOVXW Latest News

Dec 9, 2024

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Nov 26, 2024

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 19, 2024

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

Nov 12, 2024

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 5, 2024

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GOVXW Latest SEC Filings

Sep 19, 2025

[424B5] GeoVax Labs, Inc. Prospectus Supplement (Debt Securities)

Aug 14, 2025

[SCHEDULE 13G/A] GeoVax Labs, Inc. Warrants SEC Filing

Aug 8, 2025

[Form 4] GeoVax Labs, Inc. Warrants Insider Trading Activity

Aug 1, 2025

[8-K] GeoVax Labs, Inc. Warrants Reports Material Event

Jul 28, 2025

[10-Q] GeoVax Labs, Inc. Warrants Quarterly Earnings Report

GOVXW Stock Data

Float 2.35M

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City SMYRNA